Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

Q: What does CUSIP 29384C108 represent in this 13F holders report?

CUSIP 29384C108 is the security identifier for TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q4 2021?

45 institutional investors reported TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 29384C108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 38,346,880
Total 13F shares: 24,861,440
Share change: +24,197,746
Total reported value: $425,110,000
Price per share: $17.12
Number of holders: 45
Value change: +$413,748,000
Number of buys: 44

Quarterly Holders Quick Answers

What is CUSIP 29384C108?
CUSIP 29384C108 identifies TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022

Recent filing periods for CUSIP 29384C108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) as of Q4 2021

As of 31 Dec 2021, Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,861,440 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, MPM ASSET MANAGEMENT LLC, 5AM Venture Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Redmile Group, LLC, StepStone Group LP, TCG Crossover Management, LLC, GOLDMAN SACHS GROUP INC, and BlackRock Inc.. This page lists 45 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.